Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,340 | 944 | 99.8% |
| Education | $22.90 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,400 | 108 | $0 (2024) |
| PFIZER INC. | $1,317 | 127 | $0 (2024) |
| ABBVIE INC. | $1,160 | 75 | $0 (2024) |
| Lilly USA, LLC | $1,038 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $891.42 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $754.03 | 47 | $0 (2024) |
| Amgen Inc. | $726.24 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $581.15 | 41 | $0 (2024) |
| GlaxoSmithKline, LLC. | $423.59 | 30 | $0 (2024) |
| Allergan, Inc. | $366.83 | 47 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,260 | 79 | PFIZER INC. ($164.11) |
| 2023 | $1,667 | 105 | ABBVIE INC. ($375.53) |
| 2022 | $1,625 | 91 | ABBVIE INC. ($277.32) |
| 2021 | $1,971 | 127 | AbbVie Inc. ($280.20) |
| 2020 | $1,593 | 113 | AstraZeneca Pharmaceuticals LP ($190.46) |
| 2019 | $1,763 | 139 | PFIZER INC. ($208.33) |
| 2018 | $1,811 | 145 | Novo Nordisk Inc ($247.23) |
| 2017 | $1,672 | 148 | Novo Nordisk Inc ($216.77) |
All Payment Transactions
947 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: PAIN | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Central Nervous System | ||||||
| 09/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: PAIN | ||||||
| 09/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: PAIN | ||||||
| 09/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 989 | 1,238 | $336,871 | $49,924 |
| 2022 | 16 | 955 | 1,172 | $354,411 | $56,324 |
| 2021 | 17 | 997 | 1,245 | $338,499 | $82,306 |
| 2020 | 19 | 936 | 1,265 | $283,247 | $69,687 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 326 | $124,272 | $13,892 | 11.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 246 | 246 | $94,566 | $11,575 | 12.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 163 | $43,870 | $6,457 | 14.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $12,767 | $4,195 | 32.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $10,281 | $3,521 | 34.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $7,912 | $2,383 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 46 | $24,545 | $2,339 | 9.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $6,105 | $1,885 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $4,982 | $1,544 | 31.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 64 | $1,920 | $609.28 | 31.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 61 | $2,556 | $532.44 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $1,057 | $486.20 | 46.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 31 | $1,362 | $286.88 | 21.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 13 | $494.00 | $160.55 | 32.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 26 | $182.00 | $57.20 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 239 | 239 | $93,688 | $12,337 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 268 | $102,912 | $11,630 | 11.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 40 | 40 | $31,769 | $10,752 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 195 | $53,235 | $7,521 | 14.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 23 | 23 | $11,569 | $3,681 | 31.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 46 | $9,006 | $3,153 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 36 | $19,620 | $1,532 | 7.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $2,583 | $1,344 | 52.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 42 | 42 | $2,214 | $1,160 | 52.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 16 | $9,872 | $729.19 | 7.4% |
About Dr. Travis Keller, MD
Dr. Travis Keller, MD is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356394985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Travis Keller, MD has received a total of $13,363 in payments from pharmaceutical and medical device companies, with $1,260 received in 2024. These payments were reported across 947 transactions from 82 companies. The most common payment nature is "Food and Beverage" ($13,340).
As a Medicare-enrolled provider, Keller has provided services to 3,877 Medicare beneficiaries, totaling 4,920 services with total Medicare billing of $258,241. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 05/17/2006
- Last Updated 09/07/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356394985
Products in Payments
- JARDIANCE (Drug) $572.61
- FARXIGA (Drug) $572.36
- VRAYLAR (Drug) $545.77
- Ozempic (Drug) $496.52
- UBRELVY (Drug) $428.35
- NURTEC ODT (Drug) $415.98
- CHANTIX (Drug) $408.08
- TRULICITY (Drug) $404.36
- XARELTO (Drug) $392.61
- MOUNJARO (Drug) $354.99
- Aimovig (Biological) $336.71
- Vascepa (Drug) $294.85
- ELIQUIS (Drug) $261.86
- Saxenda (Drug) $243.25
- XIFAXAN (Drug) $238.28
- EMGALITY (Drug) $187.34
- INVOKANA (Drug) $169.56
- TRELEGY ELLIPTA (Drug) $164.80
- NOCDURNA (Drug) $164.14
- PREVNAR 20 (Biological) $154.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Constance Irick, M.d, M.D
Family Medicine — Payments: $21,543
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Dr. Young Cho, M.d, M.D
Family Medicine — Payments: $5,229
Kathryn Chartrand, Do, DO
Family Medicine — Payments: $4,596